Company
crownbio
Crown Bioscience is a Contract Research Organization (CRO) specializing in translational oncology and immuno-oncology drug discovery and development.
Also known as Crown Bioscience
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Customers
- biotech and pharmaceutical companies
- Legal name
- Crown Bioscience, Inc.
- crownbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Crown Bioscience is a Contract Research Organization (CRO) specializing in translational oncology and immuno-oncology drug discovery and development. Our preclinical and translational services enable biotech and pharmaceutical companies to remove the guesswork from their research and development. We are driven by our mission to empower our customers to improve human health across the globe. To do this, we engage the finest scientific talent, uphold the highest quality standards, and relentlessly pursue innovation.
Funding snapshot
- Total raised
- $30.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $30.5M2011-04-18
Funding rounds
- Round, 2011
- $30.5M2011-04-18, SEC form D sold, 14 investors
Loading relationship preview